Engineering intracellular sialylation pathways

Abstract

Methods for manipulating carbohydrate processing pathways in cells of interest are provided. Methods are directed at manipulating multiple pathways involved with the sialylation reaction by using recombinant DNA technology and substrate feeding approaches to enable the production of sialylated glycoproteins in cells of interest. These carbohydrate engineering efforts encompass the implementation of new carbohydrate bioassays, the examination of a selection of insect cell lines and the use of bioinformatics to identify gene sequences for critical processing enzymes. The compositions comprise cells of interest producing sialylated glycoproteins. The methods and compositions are useful for heterologous expression of glycoproteins.

Description

[0001] This application claims benefit under 35 U.S.C. section 119(e) based on copendino U.S. Provisional Application Ser. No. 60 / 227,579, filed Aug. 25, 2000, which is herein incorporated by reference in its entirety, and also claims benefit under 35 U.S.C. section 120 to U.S. application Ser. No. 09 / 516,793, filed Mar. 1, 2000, which is herein incorporated by reference in its entirety and which claims benefit under 35 U.S.C. section 119(e) based on U.S. Provisional Applications Nos. 60 / 169,624, filed Dec. 8, 1999, and 60 / 122,582, filed Mar. 2, 1999, both of which are herein incorporated by reference in their entireties.[0002] Part of the work performed during the development of this invention utilized U.S. Government funds in the form of grants from the National Science Foundation, Grant Numbers BES9814157, BES9814100, and the National Institutes of Health, Grant Number RO1-GM-49734. The U.S. Government has certain rights in this invention.FIELD OF THE INVENTION [0003] The inventi...

AI Technical Summary

Benefits of technology

"The patent describes methods for producing glycoproteins with sialylated oligosaccharides in different types of cells. This involves adding a donor substrate, cytidine monophosphate-sialic acid (CMP-SA), onto a specific acceptor carbohydrate (GalGlcNAcMan-R) via an enzymatic reaction catalyzed by a sialyltransferase in the Golgi apparatus. The methods involve enhancing the production of the limiting components and using polynucleotide sequences encoding the enzymes involved. The invention also provides an assay for sialylation and cells of interest that have been recombinantly engineered to produce new forms of sialylated glycoproteins."

Problems solved by technology

Thus, carbohydrate processing is specific and limiting in a wide variety of organisms including insect, yeast, mammalian, and plant cells.

The inability of insect cell lines to generate complex carbohydrates comprising sialic acid significantly limits the wider application of this expression system.

Unfortunately, Man and GlcNAc are the residues most commonly found on the termini of glycoproteins produced by insect cells.

However, the in vivo activity of the insect cell-derived product was substantially lower due to its rapid clearance from injected rats.

In addition, sialic acid and CMP-sialic acid are not permeable to cells so these substrates can not be provided directly to the medium of the cultures (Bennett et al.

Images